New president for Sandoz's US operations
This article was originally published in Scrip
Sandoz, the generics arm of Novartis, has named Don DeGolyer president of US operations and head of commercial operations for North America, effective April 1st. He will also become a member of Sandoz's executive committee. Mr DeGolyer was most recently senior vice-president and head of US commercial operations for Sandoz US. Before, he was senior vice-president of US managed markets & established medicines for Novartis Pharmaceuticals, the US affiliate of Novartis. Mr DeGolyer has also worked at Pfizer, Johnson & Johnson and Oxford GlycoSciences. Sandoz has also appointed Richard Tremonte vice-president of US retail sales and marketing, having previously served as senior director of marketing for Sandoz US, after joining in 2007. Mr Tremonte has worked in the generics industry for most of the past ten years, including more than five years at Teva Pharmaceuticals in various marketing and supply chain positions.